Mouse models inform potential treatments for Fragile X, Phelan-McDermid syndromes

FHS
June 26, 2024
5:14 am

Studies of mouse models of Fragile X syndrome and Phelan-McDermid syndrome show that treatment with cannabidiol (CBD) and the diabetes drug metformin can alleviate behavioral difficulties, according to research presented today (Wednesday) at the Federation of European Neuroscience Societies (FENS) Forum 2024.

New migraine drug atogepant shows quick relief

A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, 2024, online issue of

December 24, 2024

Mediterranean diet vs. Ultra-processed foods: Impact on frailty in older adults

Researchers evaluate whether ultra-processed food and Mediterranean diet scores were associated with frailty and cardiometabolic disease in older adults.

September 6, 2024

Finnish biotech startup Solu raises €1M to combat global antibiotic resistance

Solu, founded in 2022, is a Finnish biotechnology company focusing on combating antibiotic resistance by building the world’s most extensive pathogen DNA library. Solu’s product

June 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.